GSK-LSD1 is a selective LSD1 inhibitor with potential anticancer activity that attenuates the expression of CTGF/CCN2, MMP13, LOXL4, and waveform proteins in cancer cells.GSK-LSD1 regulates the cell cycle, induces apoptosis, and can be used to study breast cancer.
Molekulargewicht:
216.32
Reinheit:
99.59%
CAS Nummer:
[1431368-48-7]
Formel:
C14H20N2
Target-Kategorie:
Histone Demethylase|||Apoptosis
T82254
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten